Can spotting occur when changing the preparation from Nuvaring to Ginoring?

Ginoring is the equivalent of the Nuvaring disc. The lesion should not affect the occurrence of an adverse reaction in the form of spotting. The disc should remain in the vagina even despite the occurrence of spotting for the next 3 weeks from 13.07. If the disc is removed in the 3rd week of use, you can do 2 things: 1) Immediately put on a new disc and start a new 3-week period of use of the disc. 2) Take a 7-day break and only then start a new 3-week period of application of the disc. This method can be chosen only if you use the disc correctly for the last 7 days: https://www.gdziepolek.pl/produkty/96195/ginoring-przyrzad/apteki If you use vaginal discs for more than 6 months, I encourage you to consult a gynecologist to determine the cause of midcyclic spotting. I also encourage you to report the occurrence of an adverse reaction (spotting). Reporting side effects allows you to increase control over medicines available on the market. We wrote more about how and why to report side effects in the article: https://www.gdziepolek.pl/artykuly/jak-i-dlaczego-zglaszac-dzialania-niepozadane I encourage you to read additional materials that may be useful: https://www.gdziepolek.pl/artykuly/czy-bac-sie-dzialan-niepozadanych-lekow https://www.gdziepolek.pl/artykuly/czym-sa-zamienniki-lekow